LodeJanSwinnenMD

Oncology • Baltimore, MD

Hematologic Oncology, Neuro-Oncology

Professor of Oncology, Johns Hopkins University School of Medicine; Visiting Professor

Join to view full profile

Dr. Swinnen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Swinnen's full profile

Already have an account?

Office
401 N. Broadway
Baltimore, MD 21231
Phone+1 410-955-8964

Fax+1 410-955-1969
Is this information wrong?

Education & Training

Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 1981 - 1983
University of Cape Town Faculty of MedicineClass of 1978

Certifications & Licensure

IL State Medical License 1981 - 2026
MD State Medical License 2002 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma Start of enrollment: 1994 Jun 01
Completed
Phase 2
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Start of enrollment: 1995 May 01
Completed
Phase 2
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma Start of enrollment: 1998 Nov 01
Completed
Phase 2
Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2001 Apr 01
Completed
Early Phase 1
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant Start of enrollment: 2004 Feb 01
Completed
Phase 2
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2004 Mar 01
Completed
Phase 2
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2006 Sep 26
Completed
Phase 2
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma Start of enrollment: 2005 Jan 01
Completed
Phase 2
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2007 Aug 23
Terminated
Phase 2
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2009 Jan 01
Terminated
Phase 2
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance Start of enrollment: 2014 Jan 07
Terminated
Phase 2
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma Start of enrollment: 2022 Jun 21
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, M...> ;Nature. 2024 Mar 27
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Kahl, B., Jegede, O., Habermann, T., Schuster, S., Weiss, M., Fenske, T., Peterson, C., Swinnen, L., Fishkin, P., Williams, M.> ;Journal of Clinical Oncology. 2024 Mar 1
3 citations
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Nancy L Bartlett, L Elizabeth Budde, Paolo F Caimi, Julie E Chang, Beth Christia...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
8 citations
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Amy E DeZern, Marianna Zahurak, Heather J Symons, Kenneth R Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip H Imus, Nina D Wagner-Johnston, Richard F Ambinde...> ;Blood. 2023 Jun 22
1 citations
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain, Amy E Dezern, Mark J Levis, Margaret M Showel, Gabrielle T Prince, Christopher S Houri...> ;Transplantation and Cellular Therapy. 2023 Mar 1
32 citations
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Craig Horbinski, Louis Burt Nabors, Jana Portnow, Joachim Baehring, Ankush Bhatia, Orin Bloch, Steven Brem, Nicholas Butowski, Donald M Cannon, Samuel Chao, Milan G Ch...> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
1 citations
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim J Fuchs, Lode J Swinnen, Suman Paul, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, Syed A...> ;Transplantation and Cellular Therapy. 2023 Apr 1
2 citations
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.
Michael S Hughes, Cole H Sterling, Ravi Varadhan, Richard F Ambinder, Richard J Jones, Ronald J Sweren, Sima Rozati, Javier Bolaños-Meade, Leo Luznik, Philip H Imus, S...> ;Leukemia & Lymphoma. 2022 Dec 1
11 citations
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
77 citations
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, L. Elizabeth Budde, Paolo Caimi, Sven de V...> ;Journal of the National Comprehensive Cancer Network. 2021 Nov 1
4 citations
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
Alexander J. Ambinder, Matthew D. Smith, Hua-Ling Tsai, Ravi Varadhan, Amy E. DeZern, William Dalton, Christian B. Gocke, Jonathan Webster, Lukasz P. Gondek, Ivana Goj...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Oct 9
5 citations
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Katherine Rappazzo, Marianna Zahurak, Maria Bettinotti, Syed Abbas Ali, Alexander J. Ambinder, Javier Bolaños-Meade, Ivan Borrello, Amy E. DeZern, Doug E Gladstone, Ch...> ;Transplantation and Cellular Therapy. 2021 Nov 1
3 citations
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary ...
Cole Sterling, Hua Ling Tsai, Matthias Holdhoff, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Christian B. Gocke, Syed Abbas Ali, Ivan Borrello,...> ;Transplantation and Cellular Therapy. 2021 Oct 1
7 citations
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pa...
Richard L. Wahl, Eric C. Frey, Heather A. Jacene, Brad S. Kahl, Steven Piantadosi, Jesus A. Bianco, Richard J. Hammes, Miah Jung, Wayne Kasecamp, Bin He, George Sgouro...> ;Cancers. 2021 Jun 6
5 citations
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Philip H. Imus, Hua Ling Tsai, Amy E. DeZern, Kevin Jerde, Lode J. Swinnen, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Nina D. Wagner-Johnston, Carol Ann Huff...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
231 citations
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Louis B. Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Pete...> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
29 citations
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
Matthias Holdhoff, Maciej M. Mrugala, Christian Grommes, Thomas Kaley, Lode J. Swinnen, Carlos Perez-Heydrich, Lakshmi Nayak> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
15 citations
Shortened-duration immunosuppressive therapy after nonmyeloablative, related HLA-haploidentical or unrelated peripheral blood grafts and post-transplantation cyclophos...
Amy E. DeZern, Hany Elmariah, Marianna Zahurak, Gary L. Rosner, Douglas E. Gladstone, Syed Abbas Ali, Carol Ann Huff, Lode J. Swinnen, Phil Imus, Ivan Borrello, Nina D...> ;Biology of Blood and Marrow Transplantation. 2020 Nov 1
21 citations
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide.
Jonathan Webster, Leo Luznik, Hua Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark Levis, Ivana Gojo, Margaret M. Showel, Gabrielle T. Prince, Javier Bol...> ;Blood Advances. 2020 Oct 27
41 citations
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
Heather J. Symons, Marianna Zahurak, Yilin Cao, Allen R. Chen, Kenneth R. Cooke, Christopher Gamper, Orly R. Klein, Nicolas J. Llosa, Elias T. Zambidis, Richard F. Amb...> ;Blood Advances. 2020 Aug 25
53 citations
Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Stu...
Daniel O. Persky, Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett, Lode J. Swinnen, Paul M. Barr, Jerome D. Winegarden, Louis S. Constine, Thomas J. ...> ;Journal of Clinical Oncology. 2020 Jul 13
21 citations
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Coh...
Suman Paul, Marianna Zahurak, Leo Luznik, Richard F. Ambinder, Ephraim J. Fuchs, Javier Bolaños-Meade, Nina Wagner-Johnston, Lode J. Swinnen, Laura Schoch, Ravi Varadh...> ;Biology of Blood and Marrow Transplantation. 2020 Sep 1
83 citations
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.
Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip H. Imus, Ivan Borre...> ;Blood Advances. 2020 Apr 28
7 citations
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia
Suman Paul, Hua Ling Tsai, Patrick Lowery, Ephraim J. Fuchs, Leo Luznik, Javier Bolaños-Meade, Lode J. Swinnen, Satish Shanbhag, Nina Wagner-Johnston, Ravi Varadhan, R...> ;Biology of Blood and Marrow Transplantation. 2020 Mar 1
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (Journal of Neuro...
Fayez Estephan, Xiaobu Ye, Omar Dzaye, Nina D. Wagner-Johnston, Lode J. Swinnen, Douglas E. Gladstone, R. F. Ambinder, David O. Kamson, Sebastian Lambrecht, Stuart A. ...> ;Journal of Neuro-Oncology. 2019 Dec 1
Join now to see all